Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2019-01-23 Director's Dealing
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Director Shareholding
Director's Dealing Classification · 100% confidence The document begins with an 'RNS Number' and explicitly states it is providing 'Additional information' via the 'National Storage Mechanism'. The content details a transaction where a Non-Executive Director (Richard Jones) purchased shares, followed by a formal notification structure mandated by the EU Market Abuse Regulation, which includes details like the person's position, nature of the transaction ('Purchase of shares'), date, and price. This structure is characteristic of insider trading disclosures. Among the provided codes, 'Director's Dealing' (DIRS) is the most specific fit for reporting personal share transactions by directors. Although it is distributed via RNS, the specific content points directly to DIRS.
2019-01-23 English
Pre-Close Trading Update
Earnings Release Classification · 99% confidence The document begins with an 'RNS Number' and is dated January 21, 2019. It is titled 'Pre-Close Trading Update' and provides unaudited financial highlights (revenues, profit expectations, brand performance, cash flow) for the year ended December 31, 2018, ahead of the preliminary results announcement. This format—a brief, high-level summary of recent performance released via an official news service (RNS) before the full formal report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR). Since it is a formal announcement disseminated through the RNS system, it fits the ER category best, as it releases key earnings figures. FY 2018
2019-01-21 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with an "RNS Number" and contains a date stamp typical of regulatory news services. The content announces the "Total Voting Rights" as of a specific date (31 December 2018) and references compliance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of mandatory, periodic disclosure regarding share capital structure, issued under regulatory rules, fits best under the general Regulatory Filings category (RNS), as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a director's dealing (DIRS). Given the explicit RNS header and the nature of the announcement, RNS is the most appropriate classification.
2019-01-02 English
Block Listing Six Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document explicitly starts with "RNS Number : 7615L" and contains information structured as a formal notification to the London Stock Exchange regarding the status of securities under various share option plans over a specific period (Block Listing Six Monthly Return). This format and content strongly indicate a regulatory filing that doesn't fit the more specific categories like 10-K, ER, or DIV. Since it is a formal regulatory announcement distributed via RNS, and it doesn't fit other specific categories like Director's Dealing (DIRS) or Share Issue (SHA) in a direct sense (it's about option pool balances), the most appropriate general category for miscellaneous regulatory announcements is RNS.
2018-12-31 English
Appointment of Non-Executive Directors
Board/Management Information Classification · 98% confidence The document is identified by the header 'RNS Number : 5965K' and explicitly states 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces the 'Appointment of Non-Executive Directors' and includes required disclosures under AIM Rules, which is typical for a regulatory news service announcement. Since the core subject is a change in senior management/board composition, the most specific category is Board/Management Information (MANG). However, because it is disseminated via the RNS system and is a formal announcement of a specific event rather than a general report, RNS (Regulatory Filings) is also a strong candidate. Given the specific nature of the announcement (Board appointment), MANG is more precise than the general RNS fallback, but RNS is the delivery mechanism and often used for such discrete corporate actions. Since the definitions prioritize specific content over the delivery mechanism unless the content is just an announcement of a report, MANG is the best fit for the subject matter. If MANG were not available, RNS would be the choice. Reviewing the definitions, MANG covers 'Announcement of changes in the company's board of directors or senior management.' This perfectly matches the document's content. The document is short and is an announcement, but it is an announcement of a management change, not an announcement of a financial report, so RPA/RNS as a fallback for 'announcement of report' does not apply as strongly as MANG for the content itself.
2018-12-17 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document explicitly starts with an 'RNS Number' and is dated 06 December 2018. The content is a formal notification regarding the 'Total Voting Rights' of Alliance Pharma PLC, referencing the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of mandatory, short-form regulatory update, distributed via the London Stock Exchange's news service (RNS), fits the definition of a general regulatory announcement. Since it is not a comprehensive report (like 10-K or IR) and doesn't fit specific categories like Director's Dealing (DIRS) or Share Issue (SHA), the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement fallback.
2018-12-06 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.